Hilgers L A, Platenburg P L, Luitjens A, Groenveld B, Dazelle T, Weststrate M W
Solvay SA, Central Laboratory, Brussels, Belgium.
Vaccine. 1994 May;12(7):661-5. doi: 10.1016/0264-410x(94)90273-9.
The adjuvanticity of a sulfolipopolysaccharide (SLP) incorporated into a squalane-in-water emulsion (SLP/S/W) was compared with that of a mineral oil-in-water (O/W) adjuvant currently used in commercial porcine vaccines. Groups of pigs were immunized twice with vaccines comprising either inactivated influenza virus (iFlu3 containing strains A/Swine, MRC-11 and X-79), inactivated pseudorabies virus (iPRV), live pseudorabies virus (PRV) or inactivated porcine parvovirus (iPPV) as antigen and SLP/S/W or O/W as adjuvant. Antibody titres in serum 2 or 3 weeks after the second immunization were measured by haemagglutination inhibition (HI) or serum neutralization (SN) assays. Both adjuvants significantly augmented the antibody responses against the antigens tested. Mean factors of increase obtained by SLP/S/W and O/W were: 315 and 91, respectively, for A/Swine; 478 and 137 for MRC-11; 362 and 128 for X-79; 69 and 49 for iPRV; and 23 and 7 for live PRV. Increased humoral immunity against live PRV was affirmed by reduced levels and duration of virus excreted by pigs after challenge with virulent PRV. Immunization of pigs with iPPV plus adjuvant SLP/S/W gave 36-fold higher titres than with O/W. It was concluded that SLP/S/W is more effective than O/W in stimulating humoral immunity against the viral antigens examined and that the two constituents SLP and S/W interact synergistically. Advantages of SLP/S/W over O/W include stronger adjuvanticity, better biocompatibility and lower doses of active substances.
将一种掺入水包角鲨烷乳液(SLP/S/W)中的磺基脂多糖(SLP)的佐剂活性,与目前商业猪用疫苗中使用的水包矿物油(O/W)佐剂进行了比较。用包含灭活流感病毒(iFlu3,含A/猪、MRC - 11和X - 79毒株)、灭活伪狂犬病病毒(iPRV)、活伪狂犬病病毒(PRV)或灭活猪细小病毒(iPPV)作为抗原以及SLP/S/W或O/W作为佐剂的疫苗对猪群进行两次免疫。在第二次免疫后2或3周,通过血凝抑制(HI)或血清中和(SN)试验测量血清中的抗体滴度。两种佐剂均显著增强了针对所测试抗原的抗体反应。SLP/S/W和O/W获得的平均增加因子分别为:A/猪,315和91;MRC - 11,478 和137;X - 79,362和128;iPRV,69和49;活PRV,23和7。在用强毒PRV攻击后,猪排出病毒的水平和持续时间降低,证实了针对活PRV的体液免疫增强。用iPPV加佐剂SLP/S/W免疫猪产生的滴度比用O/W高36倍。得出的结论是,SLP/S/W在刺激针对所检测病毒抗原的体液免疫方面比O/W更有效,并且SLP和S/W这两种成分具有协同相互作用。SLP/S/W相对于O/W的优势包括更强的佐剂活性、更好的生物相容性和更低剂量的活性物质。